What are ADMA Biologics's profit margins?

Gross margin is 61.3% and operating margin is 42.1%, with a 32.4% net margin.

Where does ADMA Biologics's income statement data come from?

Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ADMA Biologics ADMA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$509.86M-0.1%	$510.17M+4.4%	$488.56M+3.0%	$474.17M+3.2%	$459.38M+7.7%
Total cost of revenue	$197.45M-9.2%	$217.41M-1.7%	$221.28M-0.7%	$222.86M+2.3%	$217.84M+5.3%
Gross profit	$312.42M+6.7%	$292.77M+9.5%	$267.28M+6.4%	$251.32M+4.0%	$241.54M+10.0%
Gross margin	61.3%+3.9pp	57.4%+2.7pp	54.7%+1.7pp	53%+0.4pp	52.6%+1.1pp
Research and development	$6.53M+37.2%	$4.76M+26.1%	$3.78M+42.0%	$2.66M+21.5%	$2.19M+20.7%
Selling, general and administrative	$94.24M+2.9%	$91.58M+0.2%	$91.39M+3.6%	$88.17M+6.8%	$82.56M+11.4%
Selling and marketing	——	$3.1M+3.3%	$3M+3.4%	$2.9M+3.6%	$2.8M+3.7%
Total operating expenses	$97.58M-3.7%	$101.32M+1.1%	$100.27M+4.8%	$95.68M+6.9%	$89.5M+11.1%
Operating income	$214.84M+12.2%	$191.44M+14.6%	$167.01M+7.3%	$155.64M+2.4%	$152.04M+9.4%
Operating margin	42.1%+4.6pp	37.5%+3.3pp	34.2%+1.4pp	32.8%-0.3pp	33.1%+0.5pp
Interest expense	$7.24M+1.8%	$7.11M-15.0%	$8.36M-17.9%	$10.19M-16.1%	$12.14M-12.9%
Other income (expense), net	-$8.5M+3.2%	-$8.79M+21.8%	-$11.24M-5.7%	-$10.63M+5.8%	-$11.28M+15.0%
Income before income taxes	$206.33M+13.0%	$182.66M+17.3%	$155.78M+7.4%	$145.01M+3.0%	$140.76M+12.0%
Income tax expense	$40.98M+14.7%	$35.73M+167%	-$53.67M+16.0%	-$63.92M+3.2%	-$66.01M+8.3%
Net income	$165.35M+12.5%	$146.93M-29.8%	$209.45M+0.2%	$208.93M+1.0%	$206.77M+4.6%
Net margin	32.4%+3.6pp	28.8%-14.1pp	42.9%-1.2pp	44.1%-0.9pp	45%-1.3pp
Diluted earnings per share	$0.68+13.3%	$0.60-30.2%	$0.860.0%	$0.86+1.2%	$0.85+3.7%
EBITDA	$222.64M+11.7%	$199.34M+14.0%	$174.91M+7.0%	$163.44M+2.3%	$159.74M+8.9%
EBITDA margin	43.7%+4.6pp	39.1%+3.3pp	35.8%+1.3pp	34.5%-0.3pp	34.8%+0.4pp
EBIT	$214.84M+12.2%	$191.44M+14.6%	$167.01M+7.3%	$155.64M+2.4%	$152.04M+9.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ADMA Biologics's profit margins?: Gross margin is 61.3% and operating margin is 42.1%, with a 32.4% net margin.
Where does ADMA Biologics's income statement data come from?: Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.